Structure Therapeutics (NASDAQ: GPCR) has seen a significant surge in pre-market trading, driven by several key factors that have captivated…
Read More »Top Gainers
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, saw its stock price surge significantly today despite the absence of any…
Read More »Gap is making headlines with a significant surge in its stock price, driven by strong first-quarter earnings and a strategic…
Read More »In a remarkable display of consumer resilience amid ongoing economic uncertainty, Burlington Stores (NYSE: BURL) reported a strong first-quarter earnings…
Read More »Immunovant, a clinical-stage biopharmaceutical company, has been making headlines with recent insider trading activities, SEC filings, and analyst opinions. This…
Read More »In a landmark deal that underscores the continuing consolidation in the energy sector, ConocoPhillips (NYSE: COP) has announced the acquisition…
Read More »In recent weeks, AST SpaceMobile has captured the attention of investors and industry experts with a series of groundbreaking announcements.…
Read More »Predictive Oncology (NASDAQ: POAI) has seen a significant surge in its stock price, driven by the announcement of positive results…
Read More »Insmed (NASDAQ: INSM) has recently been in the spotlight following a significant surge in its stock price. This rise is…
Read More »Bicycle Therapeutics (NASDAQ: BCYC) is making headlines with a significant pre-market surge, driven by a series of strategic moves and…
Read More »









